Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction

Abstract

Abstract Fixed dose regimen is currently the standard administration method for TKI. However, this case report indicated that TDM may by a useful approach to individualized dosing of TKI for the treatment of CML when initiating dialysis.

Keywords

• acute renal dysfunction
• chronic myeloid leukemia
• dialysis
• Imatinib
• therapeutic drug monitoring